Agilent Technologies, Inc.
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG000C2V3D6
A
Agilent Technologies, Inc.
GICS: 35203010
·
Sector: Healthcare
·
Sub-Sector: Medical - Diagnostics & Research
NAME
Agilent Technologies, Inc.
ISIN
US00846U1016
TICKER
A
MIC
XNYS
REUTERS
A.N
BLOOMBERG
A US
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Thu, 14.11.2024
Agilent Technologies
US00846U1016
Agilent Technologies Inc. (NYSE: A) announces the new Mito-rOCR Assay Kit. This easy and streamlined end-to-end solution makes sophisticated analysis of mitochondrial function available to researchers of all skill levels. With this cost-effective and versatile kit, researchers can easily incorporate functional assessment of relative mitochondrial ...
Agilent Technologies
Wed, 06.11.2024
Agilent Technologies
US00846U1016
Agilent Technologies Inc. (NYSE: A) today announced that Professor Isabelle Plante at Institut National de la Recherche Scientifique (INRS), and Professor Bangyan Stiles at the University of Southern California (USC) are recipients of an Agilent Solutions Innovation Research Award (SIRA). The honorees will receive separate awards on behalf of thei...
Agilent Technologies
Mon, 21.10.2024
Agilent Technologies
US00846U1016
Agilent Technologies Inc. (NYSE: A) today announced the release of its next generation Agilent InfinityLab LC Series portfolio, which includes the 1290 Infinity III LC, 1260 Infinity III Prime LC, and 1260 Infinity III LC systems, all including the biocompatible versions. These are the first HPLC systems on the market to feature the new Agilent In...
Agilent Technologies
Wed, 16.10.2024
Agilent Technologies
US00846U1016
Agilent Technologies Inc. (NYSE: A) will release financial results for the fourth quarter of fiscal year 2024 after the stock market closes on Monday, Nov. 25. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PST.
To join the listen-only conference call webcast, click the link on the Events section of Agile...
Agilent Technologies
Mon, 30.09.2024
Agilent Technologies
US00846U1016
Agilent Technologies Inc. (NYSE: A) will host an Analyst and Investor Day in New York City on Tuesday, Dec. 17, at 10 a.m. ET.
CEO Padraig McDonnell, CFO Bob McMahon, and other senior business leaders will present information regarding Agilent’s strategy, businesses, and long-term financial outlook. The event will conclude with a Q&A session....
Agilent Technologies
Fri, 20.09.2024
Agilent Technologies
US00846U1016
Agilent Technologies Inc. (NYSE: A) today announced the company has completed its acquisition of BIOVECTRA, a Canada-based contract development and manufacturing organization (CDMO) that specializes in biologics, highly potent active pharmaceutical ingredients, and other molecules for targeted therapeutics.
This press release features multimedia. ...
Agilent Technologies
Wed, 18.09.2024
Agilent Technologies
US00846U1016
Agilent Technologies, Inc. (NYSE: A) today announced a quarterly dividend of 23.6 cents per share of common stock will be paid on Oct. 23, 2024, to all shareholders of record as of the close of business on Oct. 1, 2024.
The timing and amounts of future dividends are subject to determination and approval by Agilent’s board of directors.
About Agi...
Agilent Technologies
Mon, 09.09.2024
Agilent Technologies
US00846U1016
Agilent Technologies Inc., (NYSE: A) today announced the launch of its Biopharma CDx Services Lab (BCSL) in Carpinteria, California, following receipt of California State clinical laboratory license and Clinical Laboratory Improvement Amendments (CLIA) certificate of compliance.
These credentials signify that the lab operates in accordance with C...
Agilent Technologies
Wed, 21.08.2024
Agilent Technologies
US00846U1016
Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.58 billion for the third quarter ended July 31, 2024, a decline of 5.6% reported and 4.4% core(1) compared to the third quarter of 2023.
Third-quarter GAAP net income was $282 million, or $0.97 per share. This compares with $111 million, or $0.38 per share, in the third quarter of ...
Agilent Technologies
Thu, 15.08.2024
Agilent Technologies
US00846U1016
Agilent Technologies Inc., (NYSE: A) today announced the release of its new Agilent J&W 5Q GC/MS Columns, representing a major advance in gas chromatography/mass spectrometry (GC/MS) column technology. Agilent has a 50-year history of innovation in gas chromatography, continually setting the standard for GC column performance. The new Agilent ...
Agilent Technologies
Information on product placements
